BTI's Magnes II cleared in Japan

Article

Magnetic source imaging developer Biomagnetic Technologies ofSan Diego announced last month that its Japanese distributor,Sumitomo Metal Industries, has received clearance from the JapaneseMinistry of Health to market its Magnes II MSI system. The

Magnetic source imaging developer Biomagnetic Technologies ofSan Diego announced last month that its Japanese distributor,Sumitomo Metal Industries, has received clearance from the JapaneseMinistry of Health to market its Magnes II MSI system. The actionmeans that Magnes II can be marketed in other Asian countriesthat recognize the Japanese agency's approval.

On the downside, BTI last month posted lower financial numbersfor its third quarter (end-June). Revenues for the quarter were$1.8 million, down 27% compared to $2.5 million in the same periodin 1994. The firm's net loss was $2.2 million, which includeda non-recurring charge of $595,000, compared to a net loss of$1.4 million in the third quarter of 1994.

The company's backlog is at $11.3 million, however, which isthe highest level in BTI's history. It was aided by an order inAugust for a Magnes Whole Head system, a next-generation MSI scannerintroduced at last year's Radiological Society of North Americameeting (SCAN 3/15/95). That system will be shipped to the Institutefor Research in Neurosciences and Psychiatry in Rouffach, France.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.